Takeda Announces Chief Financial Officer Succession

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Oncology

Costa Saroukos

More Like This

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting

Takeda Announces New Assignments of Directors

Takeda Announces New Assignments of Directors

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO

Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion